Proteomics analysis of serum from mutant mice reveals lysosomal proteins selectively transported by each of the two mannose 6-phosphate receptors.
Most mammalian cells contain two types of mannose 6-phosphate (Man-6-P) receptors (MPRs): the 300 kDa cation-independent (CI) MPR and 46 kDa cation-dependent (CD) MPR. The two MPRs have overlapping function in intracellular targeting of newly synthesized lysosomal proteins, but both are required for efficient targeting. Despite extensive investigation, the relative roles and specialized functions of each MPR in targeting of specific proteins remain questions of fundamental interest. One possibility is that most Man-6-P glycoproteins are transported by both MPRs, but there may be subsets that are preferentially transported by each. To investigate this, we have conducted a proteomics analysis of serum from mice lacking either MPR with the reasoning that lysosomal proteins that are selectively transported by a given MPR should be preferentially secreted into the bloodstream in its absence. We purified and identified Man-6-P glycoproteins and glycopeptides from wild-type, CDMPR-deficient, and CIMPR-deficient mouse serum and found both lysosomal proteins and proteins not currently thought to have lysosomal function. Different mass spectrometric approaches (spectral count analysis of nanospray LC-MS/MS experiments on unlabeled samples and LC-MALDI/TOF/TOF experiments on iTRAQ-labeled samples) revealed a number of proteins that appear specifically elevated in serum from each MPR-deficient mouse. Man-6-P glycoforms of cellular repressor of E1A-stimulated genes 1, tripeptidyl peptidase I, and heparanase were elevated in absence of the CDMPR and Man-6-P glycoforms of alpha-mannosidase B1, cathepsin D, and prosaposin were elevated in the absence of the CIMPR. Results were confirmed by Western blot analyses for select proteins. This study provides a comparison of different quantitative mass spectrometric approaches and provides the first report of proteins whose cellular targeting appears to be MPR-selective under physiological conditions.
Qian
Meiqian
M
Center for Advanced Biotechnology and Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Sleat
David E
DE
Zheng
Haiyan
H
Moore
Dirk
D
Lobel
Peter
P
D000818:Animals; D015153:Blotting, Western; D001921:Brain / Q000378:metabolism; D015180:Electrophoresis, Gel, Two-Dimensional; D006023:Glycoproteins / Q000097:blood / Q000302:isolation & purification; D008360:Mannosephosphates / Q000302:isolation & purification / Q000378:metabolism; D013058:Mass Spectrometry; D051379:Mice; D008817:Mice, Mutant Strains; D021381:Protein Transport; D011506:Proteins / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D040901:Proteomics / Q000379:methods*; D017527:Receptor, IGF Type 2 / Q000737:chemistry / Q000378:metabolism*; D015203:Reproducibility of Results; D044967:Serum / Q000737:chemistry*; D000091346:Tripeptidyl-Peptidase 1
D006023:Glycoproteins; D008360:Mannosephosphates; D011506:Proteins; D017527:Receptor, IGF Type 2; C000717268:Tpp1 protein, mouse; D000091346:Tripeptidyl-Peptidase 1; C018589:lysosomal proteins; C027693:mannose-6-phosphate